Literature DB >> 1415870

The search for meaning: RU 486 and the law of abortion.

S S Banwell1, J M Paxman.   

Abstract

The advent of RU 486 (mifepristone), a steroid analogue capable of inducing menses within 8 to 10 weeks of a missed menstrual period, has provoked a firestorm of concern and controversy. When used in conjunction with prostaglandin (RU 486/PG), it is at least 95% effective. Used in France principally to terminate confirmed pregnancies very early in the process of gestation, RU 486 raises many interesting legal questions. This article focuses on whether and how RU 486/PG can be accommodated within the framework of the world's current abortion laws. Four avenues are explored and conclusions drawn. First, it is clear that RU 486/PG can be used readily, if approved, within the regimens established by liberal abortion laws, as has been the experience in France, the United Kingdom, and even China. Second, although unlikely, the introduction of this new technology may inspire a reexamination of restrictive abortion statutes themselves. Third, some of the presently restrictive laws may be interpreted to permit RU 486/PG use as a legal procedure, for a very narrow range of reasons. Finally, in some settings the early use of RU 486/PG (before pregnancy can be confirmed) may fall outside the reach of abortion legislation and hence be acceptable from a legal point of view.

Entities:  

Keywords:  Analytical Approach; Genetics and Reproduction; Legal Approach; Roussel Uclaf

Mesh:

Substances:

Year:  1992        PMID: 1415870      PMCID: PMC1695867          DOI: 10.2105/ajph.82.10.1399

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  17 in total

1.  Legal aspects of menstrual regulation: some preliminary observations.

Authors:  Luke T Lee; John M Paxman
Journal:  J Fam Law       Date:  1975

2.  Anti-progesterones and the law.

Authors:  R J Cook
Journal:  IPPF Med Bull       Date:  1986-10

3.  Brazil: misuse of misoprostol as an abortifacient may induce malformations.

Authors:  P S Schönhöfar
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

4.  Induced abortion: a world review, 1990.

Authors:  S K Henshaw
Journal:  Fam Plann Perspect       Date:  1990 Mar-Apr

Review 5.  Prospective usefulness of RU 486 in fertility control.

Authors:  T Agoestina
Journal:  Contraception       Date:  1987       Impact factor: 3.375

6.  Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.

Authors:  F Olajide; R J Howell; J A Wass; J M Holly; H Bohn; J G Grudzinskas; M G Chapman; T Chard
Journal:  Hum Reprod       Date:  1989-04       Impact factor: 6.918

7.  Innovations in reproductive health care: menstrual regulation policies and programs in Bangladesh.

Authors:  R Dixon-Mueller
Journal:  Stud Fam Plann       Date:  1988 May-Jun

8.  Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.

Authors:  R Frydman; H Fernandez; J C Pons; A Ulmann
Journal:  Hum Reprod       Date:  1988-08       Impact factor: 6.918

9.  Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).

Authors:  M W Rodger; D T Baird
Journal:  Contraception       Date:  1989-10       Impact factor: 3.375

10.  What's new in pregnancy tests.

Authors:  M C Brucker; N J MacMullen
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  1985 Sep-Oct
View more
  2 in total

1.  RU 486.

Authors:  A Rosenfield
Journal:  Am J Public Health       Date:  1992-10       Impact factor: 9.308

2.  Induced abortion and health as a value.

Authors:  M Susser
Journal:  Am J Public Health       Date:  1992-10       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.